Sedation Methods for Broken Bones Treatment
(DRIFT Trial)
Trial Summary
What is the purpose of this trial?
This protocol describes a multicenter, prospective randomized superiority trial comparing functional outcomes between children treated with sedated reduction versus no formal reduction.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment for sedation methods in broken bones treatment?
Research shows that using sedation methods like ketamine or propofol for closed reduction (realigning broken bones without surgery) in children is effective, as it helps restore proper bone alignment and avoids the need for general anesthesia. Studies indicate that these methods are safe and do not lead to higher rates of complications or poor bone alignment after treatment.12345
Is sedation for fracture treatment generally safe in humans?
Research on sedation for fracture treatment, especially in children, shows that it is generally safe when performed in emergency departments. Safety measures like monitoring oxygen levels are commonly used, but there are inconsistencies in how adverse events are defined and reported across studies.12467
How does the treatment of closed reduction with sedation for broken bones differ from other treatments?
Closed reduction with sedation is unique because it involves realigning broken bones without surgery, using sedation to keep the patient comfortable and still during the procedure. This method is cost-effective and timely, often performed in emergency departments, and can use different sedation drugs like ketamine or propofol, which vary in duration and effects.12589
Research Team
Jospeh Janicki, MD
Principal Investigator
Ann and Robert H. Lurie Children's Hospital of Chicago
Eligibility Criteria
This trial is for boys and girls aged 4-10 with a specific type of broken wrist bone (distal radius fracture) that happened within the last 10 days. They must be able to undergo treatment in an OR or ED, and their parents need to consent and commit to the study's requirements. Children with growth plate involvement, open or pathological fractures, neuromuscular or metabolic diseases are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either immobilization in a cast without reduction or closed reduction under conscious sedation followed by casting
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Participants are monitored for long-term outcomes and any late complications
Treatment Details
Interventions
- Immobilization
- Reduction
Reduction is already approved in United States, European Union, Canada for the following indications:
- Distal radius fractures
- Mildly displaced fractures
- Distal radius fractures
- Mildly displaced fractures
- Pediatric fractures
- Distal radius fractures
- Mildly displaced fractures
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ann & Robert H Lurie Children's Hospital of Chicago
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator